OIG
Draft Compliance Guidance For the DMEPOS Industry Releasedby A. Maureen Hanna
OIG
Draft Compliance Guidance For the DMEPOS Industry Released
by A. Maureen Hanna
On January 28, 1999 the Office of Inspector General (OIG) released it's draft on compliance program guidance for the durable medical equipment, prosthetics, orthotics and supply (DMEPOS) industry.
Through the notice, published in the Federal Register, the OIG is setting forth its general views on the value and fundamental principles of DMEPOS suppliers' compliance programs as well as specific elements that a supplier should consider when developing and implementing an effective compliance program.
The creation of compliance program guidance has become a major initiative of the OIG in its efforts to engage the private health care community in addressing and fighting fraud and abuse. Recently the OIG has developed and issued compliance program guidelines directed at various segments of the health care industry including: clinical laboratories, hospitals, and home health agencies. Solicitation of information and recommendations for development of the program guidance for the hospice industry is underway.
The seven elements the OIG has determined are fundamental to an effective compliance program for the DMEPOS industry are:
1. Implementing written policies, procedures
and standards of conduct;
2. Designating a compliance officer
and compliance committee;
3. Conducting effective training
and education;
4. Developing effective lines of communication;
5. Enforcing standards through well-publicized
disciplinary guidelines;
6. Conducting internal monitoring
and auditing; and
7. Responding promptly to detected
offenses and developing corrective action.
 |
 |
 |
 |
 |
 |
 |
 |